AIGH Capital Management Takes 2.3M Share Stake in Kiora Pharma
Ticker: KPHMW · Form: SC 13G · Filed: Feb 7, 2024 · CIK: 1372514
| Field | Detail |
|---|---|
| Company | Kiora Pharmaceuticals Inc (KPHMW) |
| Form Type | SC 13G |
| Filed Date | Feb 7, 2024 |
| Risk Level | low |
| Pages | 4 |
| Reading Time | 5 min |
| Sentiment | bullish |
Complexity: simple
Sentiment: bullish
Topics: institutional-ownership, insider-buy, pharmaceuticals
TL;DR
**AIGH Capital Management just bought 2.3 million shares of Kiora Pharma, a big new institutional stake!**
AI Summary
AIGH Capital Management, LLC, a Maryland-based entity, has reported beneficial ownership of 2,300,000 shares of Kiora Pharmaceuticals, Inc. (KPRX) common stock as of February 1, 2024. This represents a significant stake, giving AIGH Capital Management sole voting and dispositive power over these shares. This matters to Kiora shareholders because a large institutional investor now holds a substantial portion of the company, potentially influencing future strategic decisions and signaling confidence in the company's prospects.
Why It Matters
This filing reveals a new significant institutional investor in Kiora Pharmaceuticals, which could bring increased scrutiny, potential influence on corporate governance, and a vote of confidence in the company's future.
Risk Assessment
Risk Level: low — The filing indicates a new institutional investor, which is generally a positive or neutral development, not an immediate risk.
Analyst Insight
A smart investor would note this new institutional ownership as a potential positive signal, suggesting a professional assessment of Kiora's value. Further research into AIGH Capital Management's investment thesis and Kiora's pipeline would be prudent.
Key Numbers
- 2,300,000 — Shares Beneficially Owned (Represents the total number of Kiora Pharmaceuticals common stock shares AIGH Capital Management, LLC has sole voting and dispositive power over.)
- February 1, 2024 — Date of Event (The specific date that triggered the requirement for this SC 13G filing, indicating when the beneficial ownership threshold was met.)
- 49721T1309 — CUSIP Number (Unique identifier for Kiora Pharmaceuticals, Inc. Common Stock, ensuring accurate identification of the security.)
Key Players & Entities
- AIGH Capital Management, LLC (company) — reporting person, beneficial owner of shares
- Kiora Pharmaceuticals, Inc. (company) — issuer of the securities
- Orin Hirschman (person) — filer of the SC 13G
- 2,300,000 (dollar_amount) — number of shares beneficially owned
Forward-Looking Statements
- AIGH Capital Management, LLC will likely maintain or increase its stake in Kiora Pharmaceuticals, Inc. over the next 6-12 months. (AIGH Capital Management, LLC) — medium confidence, target: 2025-02-01
FAQ
Who is the reporting person in this SC 13G filing?
The reporting person is AIGH Capital Management, LLC, with an I.R.S. Identification No. of 27-4413262, and its place of organization is Maryland, as stated in the filing.
What is the total number of shares beneficially owned by the reporting person?
AIGH Capital Management, LLC beneficially owns an aggregate amount of 2,300,000 shares of Kiora Pharmaceuticals, Inc. Common Stock, as detailed in Row 9 of the cover page.
What type of power does AIGH Capital Management, LLC have over these shares?
AIGH Capital Management, LLC has sole voting power over 2,300,000 shares and sole dispositive power over 2,300,000 shares, as indicated in Rows 5 and 7 of the cover page.
When was the event that required this filing?
The date of the event which required the filing of this statement was February 1, 2024, as specified on the first page of the Schedule 13G.
Under which rule was this Schedule 13G filed?
This Schedule 13G was filed under Rule 13d-1(c), as indicated by the checked box on the first page of the filing.
Filing Stats: 1,192 words · 5 min read · ~4 pages · Grade level 8.3 · Accepted 2024-02-07 09:22:54
Filing Documents
- formsc13g.htm (SC 13G) — 87KB
- 0001493152-24-005214.txt ( ) — 88KB
(a) above and Item 4 of each cover page
Item 2(a) above and Item 4 of each cover page. (d) Title of Class of Securities: Common Stock (e) CUSIP Number: 49721T1309 ITEM 3: IF THIS STATEMENT IS FILED PURSUANT TO §§240.13D-1(B) OR 240.13D-2(B) OR (C), CHECK WHETHER THE PERSON FILING IS A: (a) Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o); (b) Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c); (c) Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c); (d) Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8); (e) An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E); (f) An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F); (g) A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G); (h) A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) A non-U.S. institution, in accordance with §240.13d-1(b)(1)(ii)(J); (k) Group, in accordance with §240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution: ___________________________. ITEM 4: OWNERSHIP. See Item s 5,6,7,8 and 9 of each cover page. ITEM 5: OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ITEM 6: OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON. Not applicable. ITEM 7: IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON